Polar Pharma India Key Ratios

BSE: 523333

₹0.82

up-down-arrow-0.04 (-4.65%)

As on 17-Sep-2013IST

Market cap

info icon

₹1 Cr

Revenue (TTM)

info icon

₹16 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-0

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 48.48 297.93 -3.00
EBIT 10.04 -173.10 -335.68 15.84 -0.83
Net Profit 0.27 -37.76 -35.27 6.31 -236.80
EPS 0.27 -37.76 -35.27 6.31 -236.80
Book Value -- -- -19.57 -34.96 -300.88
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-12Mar-11
EBIT-Margin info -5,328.48-4,234.29---26.41-2.83
Net Margin info -3,838.53-2,937.69---115.14-122.35
Return on equity info 0.00-22.72--0.000.00
Return on Capital info -14.14-44.50---20.34-0.94
Return on Assets info -55.73-69.73-84.89-69.05-45.33
Debt to Equity (x) info ----0.00-1.16-1.23
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
-20.34
-0.94
-21.14
-176.22
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
--
--
--
--
Peer Median
9.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-84.89

Lower than Peers by 92.01

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
-84.89
-69.05
-45.33
-52.80
-176.47
Peer Median
7.12
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
-26.41
-2.83
-15,956.19
-5,175.76
Peer Median
5.25
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
-115.14
-122.35
-11,278.09
-3,163.24
Peer Median
4.35
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
-102.73
-103.57
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

--

--

Year on year growth in net sales

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
48.48
--
-89.37
-99.01
Peer Median
7.89
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-335.68

Lower than Peers by 340.82

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
-335.68
-1,284.47
92.92
67.22
-401.92
Peer Median
5.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-35.27

Lower than Peers by 49.21

Year on year growth in profit after tax

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
-35.27
-39.66
15.93
76.31
-2,547.98
Peer Median
13.94
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-35.27

--

Year on year growth in earnings per share

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
-35.27
-39.66
15.93
76.31
-2,547.98
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
-19.57
-16.30
-24.04
-6,888.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
-1.16
-1.23
-1.26
-1.29
Peer Median
0.15
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

-1.16

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
-1.16
-1.16
-1.23
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.02

Lower than Peers by 1.27

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
0.02
0.03
0.07
0.66
0.46
Peer Median
1.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.01

Lower than Peers by 0.88

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
0.01
0.02
0.04
0.61
0.41
Peer Median
0.88
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-0.27

Lower than Peers by 5.44

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
-0.27
-0.27
-0.02
-0.36
-14.30
Peer Median
5.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
0.98
16.06
96.14
10.22
Peer Median
17.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
0.59
0.37
0.00
0.01
Peer Median
1.42
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
21.53
29.75
350.91
4,544.30
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
56.26
66.50
7,634.12
2,963.88
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
106.76
290.69
--
136.34
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
-28.96
-194.44
7,985.02
7,371.84
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
--
--
--
--
Peer Median
185.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

-0.01

Lower than Peers by 5.82

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
-0.01
-0.02
-0.03
-0.04
-0.04
Peer Median
5.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
--
--
--
--
--
Peer Median
0.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-64.09

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
-64.09
-74.16
58.52
-54.48
-9.73
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

1

Lower than Peers by 357

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Polar Pharma India
1
3
3
3
3
Peer Median
358
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...